Columbia University

Technology Ventures

Latest News

Baker McKenzie Deploys Bespoke Artificial Intelligence (AI) to Enhance M&A and Transactional Practices

Published: August 3rd, 2017

The Center for Advancing Innovation presents the Freedom from Cancer Startup Challenge (FCSC), a unique initiative to advance and commercialize 100+ cancer inventions through high-impact startups.

Applications are now open for the fifth cycle of PowerBridgeNY! If you are a researcher, post-doctoral candidate, or PhD candidate with a promising technology that could have a positive environmental impact – we want to talk to you!

This article reviews some of the lessons learned by Columbia University in five years of managing or co-managing proof-of-concept center accelerators for grant-funded technologies in three industries: medical devices, diagnostics, and imaging; clean energy; and media.

A new study by the Milken Institute ranks Columbia University as number two in the country for commercializing science and technology emerging from university research labs.

TheraPten Biosciences Inc., a Canadian biotechnology company, has entered into an exclusive licensing agreement with Columbia University on two globally issued patent families covering PTEN-L, a naturally-occurring tumor suppressor protein.

Applied Therapeutics Inc., today announced the closing of its Series A financing round. The financing was led by Alexandria Venture Investments alongside E Squared Capital Management, Franklin Berger, ETP Global Fund and Syno Capital. Joel S.